Home
Agensys, Inc.

Agensys, Inc. Market Share Analysis for June 2026

Industry: N/A

Domainagensys.com

Year Founded1997

Employees201 - 500

Annual Revenue$15M - $25M

Agensys, Inc.

Agensys, Inc. (including company regionals)

agensys.com

See more website traffic and engagement information

Agensys, Inc. Revenue up to June 2026 is 15M - 25M

revenue generated by Agensys, Inc. top domains

Agensys, Inc. top domains revenue over 3 years

Revenue for Agensys, Inc. top domains

agensys.com15M - 25M

See more with Sales Intelligence

Total visits to Agensys, Inc.'s top domains

Understand Agensys, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Agensys, Inc.'s top domains

Analyze Agensys, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Agensys, Inc.'s top domains

See how Agensys, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Agensys, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Agensys, Inc.

These are the website technologies, by industry, used by Agensys, Inc. top domains

Content Management System (1)

Wix

Email Services (1)

Microsoft Exchange Online

Mobile (1)

Apple Mobile Tags

Widget (1)

General Captcha

News & Signals from Agensys, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAgensys sells assets to CytomX Therapeutics, Inc.Clinical-stage and oncology-focused biopharmaceutical company CytomX Therapeutics, pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, has acquired drug-conjugate linker-toxin and CD3-based bispecific technologies from Agensys, an affiliate of Astellas Pharma.

NewsAgensys sells assets to Kite Pharma in the amount of $135M.In a case of biotech deal making, Gilead Sciences Inc. subsidiary Kite Pharma Inc. has purchased a one-story, 160,000-square-foot building at 1800 Stewart St. in Santa Monica from Agensys Inc. for $135 million, or nearly $844 a square foot, according to CoStar Group Inc.

NewsAgensys is developing monoclonal antibodies for cancer treatment.Agensys focuses on developing monoclonal antibodies for cancer treatment.